recombinant toxin

recombinant toxin

'Magic bullet' A hybrid cytotoxic protein made by recombinant DNA technology, designed to selectively kill malignant cells. See Immunotoxin, Magic bullet.
Mentioned in ?
References in periodicals archive ?
Ipsen's leading recombinant toxin expertise combined with the extensive knowledge at IMCB in respect to endomembrane biology and toxin intracellular trafficking expands our research capabilities towards innovative therapeutic solutions in neurology.
Singapore : Ipsen, MCB announce research partnership to study intracellular trafficking of BoNTs within neurons
Ipsen will own exclusive worldwide rights on any candidate recombinant toxin resulting from the collaboration, while Harvard will earn associated upfront, milestones and royalty payments.
Ipsen signs research and development collaboration with Harvard Medical School
In summary, we performed the functional analysis of new recombinant toxin protein developed from two distinctly unrelated Bt cry1Ac and spider Hvt (ACTX) genes.
A Chimeric Protein Encoded by Synthetic Genes Shows Toxicity to Helicoverpa armigera and Spodotera littoralis Larvae
Also, Ipsen will have exclusive worldwide rights on any candidate recombinant toxin stemming from the collaboration and will be responsible for the development and marketing of the new toxins and will make associated upfront, milestones and royalty payments to Harvard.
Ipsen enters into sponsored research agreement with Harvard Medical School to discover novel engineered botulinum toxins
The second grant, in the amount of $131,702, is for the study of peptide and recombinant toxin therapies based on the peptide chlorotoxin, a component of scorpion venom, for glioma, a deadly cancer of the brain.
TransMolecular, Inc. Receives Two Phase I SBIR Grants
5] cells per well with RPMI-10 (RPMI with 10% fetal calf serum [FCS]) containing varying dilutions of recombinant toxins.
Superantigens and streptococcal toxic shock syndrome
who is the principal investigator for the research and development of cancer treatment agents using recombinant toxins under this grant.
Scott & White Cancer Researcher Signs Contract to Help Develop Drugs; Chemotherapy to Target Tumors and Bypass Healthy Tissue
6,028,174, which cover the use of peptide and recombinant toxins, based on chlorotoxin a component of scorpion venom, and monoclonal antibodies, which specifically bind to glial-derived or meningioma-derived tumor cells.
TransMolecular, Inc. Announces Issuance of Three U.S. Patents

Medical browser ?
Full browser ?